Drug intelligence / Profile preview

MSV-CMT

Development stage
Unknown
Lead developer
Institut de Teràpia Regenerativa Tissular
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intralesional
01

Overview

MSV-CMT is an autologous cell therapy consisting of bone marrow-derived mesenchymal progenitor cells (MSCs) expanded under Good Manufacturing Practice (GMP) conditions. Developed by the Institut de Terapia Regenerativa Tissular (ITRT) in Spain, the therapy is designed to promote salivary gland regeneration and restore glandular function in patients suffering from xerostomia (dry mouth), particularly following radiotherapy for head and neck cancer. The mechanism involves the potential of MSCs to differentiate into salivary gland-like cells or provide paracrine support to stimulate endogenous repair of damaged acinar cells. It is currently being evaluated in Phase II clinical trials.

Other names
autologous bone marrow mesenchymal progenitor cellsautologous bone marrow-derived mesenchymal stem cells

Beyond the preview

Go deeper on MSV-CMT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSV-CMT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call